Respiratory imaging technology company 4DMedical (ASX:4DX) has announced the renewal and extension of the contract for its pulmonary function software-as-a-service analysis with the Cleveland Clinic.
The Cleveland Clinic is an academic medical centre globally recognised for its cutting-edge research and excellence in clinical practice. Cleveland consistently ranks in the top three hospitals in the US and in the top 10 for pulmonology. The main campus in Cleveland, Ohio, is a 1,000-bed multi-specialty clinical and research facility.
4DMedical said the renewed agreement for functional lung imaging extends over three years, with a minimum contract value of $227,000, and layers on top of an existing multi-year agreement for its pulmonary structure products.
4DMedical’s software-as-a-service platform provides advanced imaging analysis, delivering insights into respiratory function. This extension ensures the Cleveland Clinic can continue leveraging 4DMedical’s innovative technology to advance respiratory health.
4DMedical managing director, CEO and founder Andreas Fouras said, We are delighted to extend our collaboration with this prestigious academic medical centre and research institution. This renewal strengthens our position as a leading provider of cutting-edge imaging solutions. Their continued trust in our technology underscores the value 4DMedical provides in the field of respiratory health.
"We have numerous opportunities to expand our existing presence at the Cleveland Clinic, with considerable interest shown at recent congresses in our current and future portfolio, including CT:VQ. I have personally been involved in several of the discussions with these leading doctors and can feel their enthusiasm for how our solutions will benefit their clinical care and workflow."